Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
1 other identifier
observational
1,470
1 country
17
Brief Summary
This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2016
Longer than P75 for all trials
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2015
CompletedFirst Posted
Study publicly available on registry
July 31, 2015
CompletedStudy Start
First participant enrolled
March 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 11, 2021
CompletedFebruary 4, 2022
July 1, 2020
5.1 years
July 24, 2015
February 3, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with adverse events as a measure of safety and tolerability
adverse events
1 year
Interventions
medical abortion
Eligibility Criteria
Women seeking abortion
You may qualify if:
- desires abortion
You may not qualify if:
- medically ineligible for procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
Planned Parenthood of the Rocky Mountains
Denver, Colorado, 80207, United States
Carafem
Washington D.C., District of Columbia, 20815, United States
Carafem
Atlanta, Georgia, 30309, United States
The University of Hawaii Women's Options Centers
Honolulu, Hawaii, 96826, United States
Carafem
Skokie, Illinois, 60076, United States
Emma Goldman Clinic
Iowa City, Iowa, 52245, United States
Maine Family Planning
Augusta, Maine, 04332, United States
Carafem
Chevy Chase, Maryland, 20815, United States
Planned Parenthood Minnesota, North Dakota, South Dakota
Saint Paul, Minnesota, 55114, United States
Planned Parenthood of Montana
Billings, Montana, 59102, United States
Planned Parenthood of the Rocky Mountains
New Mexico, New Mexico, 80207, United States
Choices Women's Medical Center
Jamaica, New York, 11435, United States
Maine Family Planning
New York, New York, 04332, United States
Planned Parenthood Columbia Willamette
Portland, Oregon, 97212, United States
Oregon Health and Sciences University Women's Health Research Unit
Portland, Oregon, 97239, United States
Planned Parenthood Columbia Willamette
Washington, Washington, 97212, United States
Oregon Health and Sciences University Women's Health Research Unit
Washington, Washington, 97239, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Erica Chong, MPH
Gynuity Health Projects
- PRINCIPAL INVESTIGATOR
Elizabeth Raymond, MD, MPH
Gynuity Health Projects
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2015
First Posted
July 31, 2015
Study Start
March 22, 2016
Primary Completion
May 11, 2021
Study Completion
May 11, 2021
Last Updated
February 4, 2022
Record last verified: 2020-07